InvestorsObserver
×
News Home

Is Omeros Corp (OMER) a Bad Choice in Biotechnology Thursday?

Thursday, March 28, 2024 11:56 AM | InvestorsObserver Analysts

Mentioned in this article

Is Omeros Corp (OMER) a Bad Choice in Biotechnology Thursday?

The 28 rating InvestorsObserver gives to Omeros Corp (OMER) stock puts it near the bottom of the Biotechnology industry. In addition to scoring higher than 13 percent of stocks in the Biotechnology industry, OMER’s 28 overall rating means the stock scores better than 28 percent of all stocks.

Overall Score - 28
OMER has an Overall Score of 28. Find out what this means to you and get the rest of the rankings on OMER!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Omeros Corp Stock Today?

Omeros Corp (OMER) stock is trading at $3.49 as of 11:55 AM on Thursday, Mar 28, a gain of $0.07, or 2.05% from the previous closing price of $3.42. The stock has traded between $3.36 and $3.51 so far today. Volume today is light. So far 76,235 shares have traded compared to average volume of 492,895 shares. Click Here to get the full Stock Report for Omeros Corp stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App